Literature DB >> 1685729

Pancreaticoduodenectomy in combination with right hemicolectomy for surgical treatment of advanced gastric carcinoma located in the lower half of the stomach.

Y Yonemura1, S Ooyama, H Matumoto, T Kamata, H Kimura, S Takegawa, T Kosaka, A Yamaguchi, K Miwa, I Miyazaki.   

Abstract

The results of surgical treatment of patients with gastric carcinoma infiltrating into the duodenum and the pancreas head and with N3 metastases are very poor. We have employed pancreaticoduodenectomy in combination with right hemicolectomy (PD + LH) with the aim of leaving no remnant of cancer cells in the vicinity of the primary lesion, in patients with carcinomas of the distal third of the stomach, associated with duodenal invasion, presence of fixity to the pancreas head or N3 metastases, in the last ten years. Twenty-six cases were treated with this technique (Group A). These cases were compared with 63 patients who underwent subtotal gastrectomy (Group B) in the same period. The operation time, amount of blood loss and numbers of operative complications were greater in Group A than in Group B. Operating mortality was found in 2 cases in Group B but was 0 for Group A. When the survival rates were compared, PD + LH can provide better long-term results than subtotal gastrectomy, especially in the patients with tumors infiltrating into the pancreas head or metastasizing to N3. The PD + LH is a rational and safe method for the treatment of gastric carcinoma infiltrating into the pancreas head or metastasizing to N3.

Entities:  

Mesh:

Year:  1991        PMID: 1685729

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  7 in total

1.  Pancreaticoduodenectomy for advanced gastric cancer with pancreaticoduodenal region involvement.

Authors:  Xin-Bao Wang; Li-Tao Yang; Ze-Wei Zhang; Jian-Min Guo; Xiang-Dong Cheng
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

Review 2.  Systematic review of pancreaticoduodenectomy for locally advanced gastric cancer.

Authors:  Patrick Roberts; Rajini Seevaratnam; Roberta Cardoso; Calvin Law; Lucy Helyer; Natalie Coburn
Journal:  Gastric Cancer       Date:  2011-08-26       Impact factor: 7.370

3.  Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Authors:  F Bataille; P Rümmele; W Dietmaier; D Gaag; F Klebl; A Reichle; P Wild; F Hofstädter; A Hartmann
Journal:  Mol Pathol       Date:  2003-10

4.  Extended local resection for advanced gastric cancer: increased survival versus increased morbidity.

Authors:  Robert C G Martin; David P Jaques; Murray F Brennan; Martin Karpeh
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

5.  Surgical results of performing R4 gastrectomy for gastric cancer located in the upper third of the stomach.

Authors:  Y Yonemura; M Segawa; H Matsumoto; K Tsugawa; I Ninomiya; L Fonseca; T Fujimura; K Sugiyama; K Miwa; I Miyazaki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Laparoscopic Whipple's Operation for Locally Advanced Gastric Cancer Invading the Pancreas and Duodenum: a Case Report.

Authors:  Chang Min Lee; Sam-Youl Yoon; Sungsoo Park; Seong-Heum Park
Journal:  J Gastric Cancer       Date:  2019-08-01       Impact factor: 3.720

7.  Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.

Authors:  Y Hirono; S Fushida; Y Yonemura; H Yamamoto; H Watanabe; A Raz
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.